Acamprosate Completed Phase 2 Trials for Drug-induced Tardive Dyskinesia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02064010A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia